Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
U.S. Renal Care, Inc. Completes Acquisition of Dialysis Corporation of America Company to serve approximately 5,500 patients through 120 dialysis programs in 9 states PR Newswire PLANO, Texas and...
U.S. Renal Care, Inc. Successfully Completes Tender Offer for Dialysis Corporation of America PR Newswire PLANO, Texas, June 2 PLANO, Texas, June 2 /PRNewswire/ -- U.S. Renal Care, Inc. ("USRC...
U.S. Renal Care, Inc. Enters Into Definitive Credit Agreements in Connection With Acquisition of Dialysis Corporation of America PR Newswire PLANO, Texas, May 25 PLANO, Texas, May 25 /PRNewswire/...
U.S. Renal Care, Inc. Announces Extension of Tender Offer for Dialysis Corporation of America PR Newswire PLANO, Texas, May 13 PLANO, Texas, May 13 /PRNewswire/ -- U.S. Renal Care, Inc. ("USRC...
The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board...
CALGARY, Alberta, April 15, 2010 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Dialysis Corp. of...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Dialysis Corporation of America, Inc. (“DCA” or the...
NEW YORK (dpa-AFX) - Gute Quartalszahlen haben den Dow Jones am Mittwoch auf ein 18-Monatshoch getrieben. Grund waren positive Überraschungen sowohl des Chipherstellers Intel...
Ryan & Maniskas, LLP is investigating whether the directors of Dialysis Corporation of America, Inc. ("Dialysis" or the “Company”) (NASDAQ:DCAI) breached their fiduciary duties...
Levi & Korsinsky is investigating the Board of Directors of Dialysis Corp. of America (“DCAI” or the “Company”) (NasdaqGM: DCAI) for possible breaches of fiduciary duty and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
